[{"Assets_0_Q2_USD":5138500000.0,"CommonStockSharesOutstanding_0_Q2_shares":211100000.0,"EarningsPerShareBasic_1_Q2_USD":0.88,"EarningsPerShareBasic_2_Q2_USD":1.97,"EarningsPerShareDiluted_1_Q2_USD":0.86,"EarningsPerShareDiluted_2_Q2_USD":1.93,"StockholdersEquity_0_Q2_USD":2939600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":215700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":216100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":210500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":210800000.0,"Ticker":"EW","CIK":"1099800","name":"EDWARDS LIFESCIENCES CORP","OfficialName":"Edwards Lifesciences Corporation Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77366347639.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NYSE","SP500":"SP500","filed":"20170728"}]